when the condition
is serious
IFR Center for Current Research
CRITICAL FINDINGS FROM TOP MEDICAL JOURNALS
|
SearchColorectal Cancer: Free Medical and Health Information on Colorectal Cancer Research and TreatmentColorectal Cancer
Search within these results:
Kaempferol is a natural compound contained in edible plants, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-cancer agent.
Kamigyo-ku, Kyoto Japan Angiogenesis plays a key role in the development of a wide variety of malignant tumors.
Shanghai, China 200031 China Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
CD147 is a multifunctional transmembrane protein and promotes cancer progression.
Osaka, Japan 537-8511 Japan This is a phase II institutional exploratory trial of biweekly irinotecan and cetuximab administration regimen in metastatic colorectal cancer patients progressing to at least one previous chemotherapy line.
Valencia, Spain Spain trans-Fatty acid consumption is known to have detrimental effects on cardiovascular health, but little is known about its role in digestive tract neoplasia.
Chapel Hill, NC 27599-7555 USA OBJECTIVE: To evaluate the effect of the time interval between chemoradiotherapy (CRT) and surgery on CRT response and surgical outcomes.
Goyang-si, Korea Korea Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/
The purpose of this study was to determine the optimal dose of oxaliplatin, when combined with a fixed dose of S-1 (40 mg/m twice daily on days 1-14) on a 3-week schedule, for patients with advanced and/or metastatic colorectal cancer.
Shanghai, China China PURPOSE: The combination of vaccines and chemotherapy holds promise for cancer therapy, but the effect of cytotoxic chemotherapy on vaccine-induced antitumor immunity is unknown.
New York, NY 10032 USA Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectab
PURPOSE: Preoperative chemoradiotherapy is considered standard treatment for locally advanced rectal cancer, although the scientific evidence for the chemotherapy addition is limited.
Oslo, Norway Norway Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as firs
PURPOSE: To evaluate the safety and efficacy of three oxaliplatin and fluoropyrimidine regimens, with or without bevacizumab, as first-line treatment for metastatic colorectal cancer (CRC).
160 East 34th St
New York, NY 10016 USA |
PartnersLinksApproved By
|
